淋巴细胞与单核细胞比值与恶性肿瘤预后的关系被引量：6

Relationship between lymphocyte-monocyte ratio and prognosis of malignant tumors

导出

摘要相关研究已经证实，肿瘤相关炎症与多种肿瘤的进展及预后相关。作为一种炎症生物标志物，淋巴细胞与单核细胞比值在预测恶性肿瘤预后中显示出重要的应用价值。它不仅可以对肿瘤患者进行恰当的风险分层，还可以给后续个体化治疗方案的制定提供依据。 Related studies have been confirmed that tumor-associated inflammation is associated with tumor progression and prognosis in a variety of tumors.As an inflammatory biomarker,lymphocyte-monocyte ratio shows significant value in predicting the prognosis of malignant tumors.It can not only be appropriate for patients with cancer risk stratification,but also provide the basis for the subsequent development of individua-lized treatment programs.

作者钱门龙卢宁

机构地区新疆医科大学研究生学院兰州军区乌鲁木齐总医院肿瘤科

出处《国际肿瘤学杂志》 CAS 2016年第10期769-771,共3页 Journal of International Oncology

关键词淋巴细胞单核细胞肿瘤预后 Lymphocytes Monocytes Neoplasms Prognosis

分类号 R730.3 [医药卫生—肿瘤]

引文网络
相关文献

参考文献19

1Landskron G, De la Fuente M, Thuwajit P, et al. Chronic inflamma- tion and cytokines in the tumor microenvironment [ J]. J Immunol Res, 2014, 2014: 149185. DOI: 10. 1155/2014/149185.
2Zhang J, Huang SH, Li H, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer[J]. Med Oncol, 2013, 30(1): 352. DOI: 10.1007/ s12032-012-0352-3.
3Botta C, Barbieri V, Ciliberto D, et al. Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients [ J ]. Cancer Biol Ther, 2013, 14 ( 6 ) : 469-475. DOI : 10. 4161/cbt. 24425.
4Li J, Jiang R, Liu WS, et al. A large cohort study reveals the associ- ation of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma [ J ]. PLoS One,2013, 8(12) : e83069. DOI: 10. 1371/journal. pone. 0083069.
5Li YL, Pan YY, Jiao Y, et al. Peripheral blood !ymphocyte/mono- cyte ratio predicts outcome for patients with diffuse large B cell lym- phoma after standard first-line regimens[ J]. Ann Hematol, 2014, 93 (4) : 6174526. DOI: 10. 1007/s00277-013-1916-9.
6Jiang R, Cai XY, Yang ZH, et al. Elevated peripheral blood lympho- cyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma[J]. Chin J Cancer, 2015, 34(6) : 237-246. DOI: 10. 1186/s40880-015-0025-7.
7Lin GN, Peng JW, Xiao JJ, et al. Prognostic impact of circulating monocytes and lymphocyte-to-monoeyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum- based doublet[J]. Med Oneol, 2014, 31(7) : 70. DOI: 10. 1007/ s12032-014--0070-0.
8Hu P, Shen H, Wang G, et al. Prognostic significance of systemic in- flammation-based lymphoeyte-monocyte ratio in patients with lung cancer: based on a large cohort study[J]. PLoS One, 2014, 9(9) : e108062. DOI: 10. 1371/joumal. pone. 0108062.
9Go SI, Kim RB, Song HN, et al. Prognostic significance of the lym- phocyte-to-monoeyte ratio in patients with small cell lung cancer[ J ]. Med Oneol, 2014, 31 (12) : 323. DOI: 10. 1007/s12032-014-0323- y.
10Chen YM, Lai CH, Chang HC, et al. Baseline and trend of lympho- cyte-to-mouocyte ratio as prognostic factors in epidermal growth factor receptor mutant non-small cell lung cancer patients treated with first- line epidermal growth factor receptor tyrosine kinase inhibitors [ J]. PLoS One, 2015, 10 (8) : e0136252. DOI: 10. 1371/journal. pone. 0136252.